Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gene Expression Profiles of Breast Cancer Treated With Sequential Adriamycin and Docetaxel in Relation to Tumor Responses

NCT00212082 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT00212082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gene Expression Profiles of Breast Cancer Treated With Sequential Adriamycin and Docetaxel in Relation to Tumor Responses
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2002
Completion date
Not reported
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer